Universal Health (UHS) Tops Q2 EPS by 42c, Offers Guidance
Universal Health (NYSE: UHS) reported Q2 EPS of $5.35, $0.42 better than the analyst estimate of $4.93. Revenue for the quarter came in at $4.28 billion versus the consensus estimate of $4.24 billion.
GUIDANCE:
Universal Health sees FY2025 EPS of $20.00-$21.00, versus the consensus of $19.58. Universal Health sees FY2025 revenue of $17.1-17.31 billion, versus the consensus of $17.13 billion.
For earnings history and earnings-related data on Universal Health (UHS) click here.
